BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30706452)

  • 1. Serum cell-free DNA levels are a useful marker for extramammary Paget disease.
    Mijiddorj T; Kajihara I; Tasaki Y; Otsuka-Maeda S; Sakamoto R; Sawamura S; Kanazawa-Yamada S; Egashira S; Inoue K; Makino K; Miyashita A; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Morinaga J; Ikeda T; Ihn H
    Br J Dermatol; 2019 Sep; 181(3):505-511. PubMed ID: 30706452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease.
    Nakamura Y; Tanese K; Hirai I; Amagai M; Kawakami Y; Funakoshi T
    Br J Dermatol; 2019 Sep; 181(3):535-543. PubMed ID: 30791097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokeratin 19 fragment 21-1 is a useful tumor marker for the assessment of extramammary Paget's disease.
    Kato J; Sumikawa Y; Hida T; Kamiya T; Horimoto K; Kamiya S; Sato S; Takahashi H; Sawada M; Yamashita T
    J Dermatol; 2017 Jun; 44(6):666-670. PubMed ID: 28150330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-155, a potential serum marker of extramammary Paget's disease.
    Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
    BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of circulating tumour DNA in metastatic extramammary Paget's disease.
    Sawamura S; Mijiddorj Myangat T; Kajihara I; Tanaka K; Ide M; Sakamoto R; Otsuka-Maeda S; Kanemaru H; Nishimura Y; Kanazawa-Yamada S; Kashiwada-Nakamura K; Honda N; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Ihn H
    Exp Dermatol; 2022 Mar; 31(3):341-348. PubMed ID: 34676917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined serum carcinoembryonic antigen and cytokeratin 19 fragment levels provide a sensitive biomarker for lymph node metastasis in extramammary Paget's disease.
    Kato H; Nakamura M; Watanabe S; Oda T; Morita A
    J Dermatol; 2020 Jul; 47(7):763-769. PubMed ID: 32415799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum cytokeratin 19 fragment 21-1 to determine the efficacy of docetaxel chemotherapy in advanced extramammary Paget's disease.
    Onishi M; Maeda F; Akasaka T; Amano H
    J Dermatol; 2019 Mar; 46(3):e83-e84. PubMed ID: 30194782
    [No Abstract]   [Full Text] [Related]  

  • 8. RANKL expression is a useful marker for differentiation of pagetoid squamous cell carcinoma in situ from extramammary Paget disease.
    Fujimura T; Kambayashi Y; Kakizaki A; Furudate S; Aiba S
    J Cutan Pathol; 2016 Sep; 43(9):772-5. PubMed ID: 27251225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease.
    Urano-Takaoka M; Sumida H; Miyagawa T; Awaji K; Nagai K; Omatsu J; Miyake T; Sato S
    Acta Derm Venereol; 2022 Jan; 102():adv00636. PubMed ID: 34904690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.
    Perrotto J; Abbott JJ; Ceilley RI; Ahmed I
    Am J Dermatopathol; 2010 Apr; 32(2):137-43. PubMed ID: 20051815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors of Extramammary Paget's Disease.
    Hatta N
    Curr Treat Options Oncol; 2018 Aug; 19(10):47. PubMed ID: 30112691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
    Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
    APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease.
    Hikita T; Ohtsuki Y; Maeda T; Furihata M
    Int J Surg Pathol; 2012 Oct; 20(5):441-8. PubMed ID: 23001873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo reflectance confocal microscopy of extramammary Paget disease: diagnostic evaluation and surgical management.
    Pan ZY; Liang J; Zhang QA; Lin JR; Zheng ZZ
    J Am Acad Dermatol; 2012 Feb; 66(2):e47-53. PubMed ID: 21620517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease.
    Tanaka R; Sasajima Y; Tsuda H; Namikawa K; Tsutsumida A; Otsuka F; Yamazaki N
    Br J Dermatol; 2013 Jun; 168(6):1259-66. PubMed ID: 23360223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handheld Reflectance Confocal Microscopy for the Detection of Recurrent Extramammary Paget Disease.
    YĆ©lamos O; Hibler BP; Cordova M; Hollmann TJ; Kose K; Marchetti MA; Myskowski PL; Pulitzer MP; Rajadhyaksha M; Rossi AM; Jain M
    JAMA Dermatol; 2017 Jul; 153(7):689-693. PubMed ID: 28492924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
    Kibbi N; Owen JL; Worley B; Wang JX; Harikumar V; Downing MB; Aasi SZ; Aung PP; Barker CA; Bolotin D; Bordeaux JS; Cartee TV; Chandra S; Cho NL; Choi JN; Chung KY; Cliby WA; Dorigo O; Eisen DB; Fujisawa Y; Golda N; Halfdanarson TR; Iavazzo C; Jiang SIB; Kanitakis J; Khan A; Kim JYS; Kuzel TM; Lawrence N; Leitao MM; MacLean AB; Maher IA; Mittal BB; Nehal KS; Ozog DM; Pettaway CA; Ross JS; Rossi AM; Servaes S; Solomon MJ; Thomas VD; Tolia M; Voelzke BB; Waldman A; Wong MK; Zhou Y; Arai N; Brackett A; Ibrahim SA; Kang BY; Poon E; Alam M
    JAMA Oncol; 2022 Apr; 8(4):618-628. PubMed ID: 35050310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated Extramammary Paget's Disease of the Unilateral Axilla in a Male Patient: A Case Report.
    Eyrich NW; Pumiglia L; Hughes TM
    Clin Breast Cancer; 2020 Jun; 20(3):e229-e231. PubMed ID: 32146095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.